Log in
Register- Dose term in the ANOVA Model balakotu 2019-06-18 13:03
![[Mix]](https://static.bebac.at/img/mix.png "open in Mix view")
- Dose term in the ANOVA Model ElMaestro 2019-06-18 13:14
- OT: BW in ANCOVA Helmut 2019-06-18 13:39
- OT: BW in ANCOVA ElMaestro 2019-06-18 15:51
- OT: BW in ANCOVA Kumarnaidu2 2021-03-05 14:56
- Dose term in the ANOVA Model balakotu 2019-06-21 07:31
- Dose term in the ANOVA Model ElMaestro 2019-06-21 20:54
- Dose term in the ANOVA Model d_labes 2021-03-06 15:22
- Dose term in the ANOVA Model ElMaestro 2019-06-21 20:54
- OT: BW in ANCOVA Helmut 2019-06-18 13:39
- Dose term in the ANOVA Model ElMaestro 2019-06-18 13:14
- in vitro study with the nasogastric tube, CI Nataliia 2021-02-16 13:08
- in vitro study with the nasogastric tube, CI dshah 2021-02-17 07:35
- in vitro study with the nasogastric tube, CI Nataliia 2021-03-01 15:37
- in vitro study with the nasogastric tube, CI dshah 2021-02-17 07:35
- Japan BE requirement mangurohit 2010-02-02 09:20
- Brazil's CROs Helmut 2010-02-02 15:03
- Bioequivalence in Japan mangurohit 2010-02-03 05:21
- Bioequivalence in Japan Helmut 2010-02-03 11:10
- Japanese Guideline of Bioequivalence Brus 2021-02-24 16:30
- Japanese Guideline of Bioequivalence Helmut 2021-02-24 18:07
- Japanese Guideline of Bioequivalence Brus 2021-02-25 11:46
- Japanese Guideline of Bioequivalence Helmut 2021-02-24 18:07
- Bioequivalence in Japan mangurohit 2010-02-03 05:21
- Brazil's CROs Helmut 2010-02-02 15:03
- Terminology: Fed study Pharma_88 2021-01-20 11:15
- Definition of Generic Drug in Mexico jag009 2021-01-05 00:25
- Chinese BE GL Helmut 2020-12-30 11:37
- Chinese BE GL ElMaestro 2020-12-30 11:54
- Chinese BE GL Helmut 2020-12-30 12:16
- no luck so far... mittyri 2020-12-30 22:23
- Chinese BE GL 0521 2021-01-04 08:31
- HVD(P)s? Helmut 2021-01-04 10:47
- HVD(P)s? 0521 2021-01-04 12:10
- China RSABE Helmut 2021-01-04 15:49
- China DNS != Google DNS mittyri 2021-01-04 22:16
- China RSABE Helmut 2021-01-04 15:49
- HVD(P)s? 0521 2021-01-04 12:10
- HVD(P)s? Helmut 2021-01-04 10:47
- Chinese BE GL ElMaestro 2020-12-30 11:54
- Biowaiver for Lower Strength vandee 2020-11-23 06:52
- Biowaiver for Lower Strength Ohlbe 2020-11-23 10:41
- Biowaiver for Lower Strength vandee 2020-11-25 06:17
- Biowaiver for Lower Strength wienui 2020-11-24 10:42
- Biowaiver for Lower Strength vandee 2020-11-25 06:21
- Biowaiver for Lower Strength Ohlbe 2020-11-23 10:41
- ambulatory samples in bioequivalence studies yoyo87 2020-11-22 10:06
- large deviations from schedule Helmut 2020-11-23 12:18
- Accepted time deviations in Ambulatory PK intervals Researcher101 2020-11-20 17:59
- Accepted time deviations in Ambulatory PK intervals ElMaestro 2020-11-21 10:08
- Accepted time deviations in Ambulatory PK intervals Researcher101 2020-11-22 11:52
- Accepted time deviations in Ambulatory PK intervals Helmut 2020-11-23 11:49
- Accepted time deviations in Ambulatory PK intervals ElMaestro 2020-11-21 10:08
- highly variable drugs-Cmax nuka2020 2020-11-19 11:09
- GCC: HV Cmax (fixed limits) Helmut 2020-11-19 12:05
- highly variable drugs-Cmax wienui 2020-11-19 18:04
- highly variable drugs-Cmax Helmut 2020-11-19 20:58
- Reference product in bioequivalence slebr 2020-11-04 10:02
- Thailand FDA Bioequivalence Guideline Pharma_88 2020-10-22 06:49
- Thailand FDA Bioequivalence Guideline Brus 2020-10-22 09:16
- Russia BE Study Anand 2015-03-27 05:28
- Russia BE Study Beholder 2015-03-27 09:46
- Russia BE Study Anand 2015-03-27 10:24
- Russia BE Study Beholder 2015-03-27 12:21
- Red Book? Helmut 2015-03-27 14:16
- Red Book? Yeah... Beholder 2015-03-29 16:36
- Red Book? Yeah... Alyssa 2020-10-05 06:00
- Red Book? Yeah... Beholder 2020-10-05 11:34
- Red Book? Yeah... Alyssa 2020-10-05 06:00
- Red Book? Yeah... Beholder 2015-03-29 16:36
- Red Book? Helmut 2015-03-27 14:16
- Russia BE Study Beholder 2015-03-27 12:21
- Russia BE Study Brus 2020-10-01 16:05
- Russia BE Study Helmut 2020-10-01 16:47
- Russia BE Study Brus 2020-10-01 16:51
- Russia BE Study Helmut 2020-10-01 17:02
- Russia BE Study Beholder 2020-10-02 09:24
- Russia BE Study Helmut 2020-10-01 17:02
- Russia BE Study Brus 2020-10-01 16:51
- Russia BE Study Beholder 2020-10-03 19:51
- Russia BE Study Brus 2020-10-21 10:42
- Russia BE Study Helmut 2020-10-01 16:47
- Russia BE Study Anand 2015-03-27 10:24
- Russia BE guidelines Ohlbe 2015-03-27 09:52
- Russia BE Study Beholder 2015-03-27 09:46
- Retention period and quantity for Malaysian submission Sriramprasad 2020-07-18 09:06
- Retention period and quantity for Malaysian submission cakhatri 2020-08-10 08:04
- Retention period and quantity for Malaysian submission Sriramprasad 2020-10-17 13:54
- Retention period and quantity for Malaysian submission cakhatri 2020-08-10 08:04
- bioequivalence criteria for NTID Biostats 2018-03-29 12:39
- bioequivalence criteria for NTID Helmut 2018-03-29 14:27
- bioequivalence criteria for NTID Biostats 2018-03-30 06:25
- GMR not relevant in ABE Helmut 2018-03-30 11:19
- Presentation of data in report and SAS output arl_stat 2020-10-15 16:12
- GMR not relevant in ABE Helmut 2018-03-30 11:19
- bioequivalence criteria for NTID Biostats 2018-03-30 06:25
- bioequivalence criteria for NTID jag009 2018-03-29 17:20
- bioequivalence criteria for NTID Helmut 2018-03-29 14:27
Ing. Helmut Schütz